Autopsy report · NCT02883361

Motivational Enhancement Therapy to Improve Adherence to Aromatase Inhibitors

Cause of deathFunding or business Automatic label, confidence 0.5, unverified. How labels are made.

“Our team decided to conduct more preliminary work on understanding AI adherence to support the optimal development of a randomized controlled trial before proceeding with the trial.”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 2, Phase 3
Sponsor: University of Calgary
Sponsor type: University, hospital or other
Conditions: Breast Cancer; Medication Adherence
Interventions: Motivational enhancement therapy; Attention Control
Participants: 0
Sites: 1
Countries: Canada

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.